News

December 11, 2017

Kimberly Blackwell, M.D., to become Vice President of Early Phase Development and Immuno-oncology at Lilly Oncology
INDIANAPOLIS, Dec. 11, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that Kimberly Blackwell, M.D., one of the nation's leading breast cancer researchers, will join Lilly Oncology as vice president of early phase development and immuno-oncology on March 12, 2018.  Dr. Blac...

November 13, 2017

Lilly Appoints Philip Johnson to Senior Vice President and Treasurer
INDIANAPOLIS, Nov. 13, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced Philip Johnson has been appointed to senior vice president, Finance, and treasurer effective January 1, 2018. Johnson currently serves as vice president for Investor Relations at Lilly. He will report to Joshua Smiley, who will become senior vice president...

October 23, 2017

Lilly announces $72 million investment in diabetes manufacturing in Indianapolis
INDIANAPOLIS, Oct. 23, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to invest $72 million in an insulin manufacturing project at one of its Indianapolis facilities. The investment will be used to replace an existing insulin vial filling line and allow Lilly to meet growing demand for its insulins - including Humalog&...

October 18, 2017

Lilly and CureVac Announce Global Collaboration to Develop mRNA Cancer Vaccines
INDIANAPOLIS and TÜBINGEN, Germany, Oct. 18, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and CureVac AG have announced a global immuno-oncology collaboration focused on the development and commercialization of up to five potential cancer vaccine products based on CureVac's proprietary RNActive® technology. The companies will us...

October 5, 2017

U.S. Patent and Trademark Office Rules In Lilly's Favor On Alimta Vitamin Regimen Patent
INDIANAPOLIS, Oct. 5, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office (PTO) has ruled in the company's favor regarding patentability of the vitamin regimen for Alimta® (pemetrexed for injection). In the inter partes review (IPR) proceed...

October 5, 2017

Additional Delivery of Insulin Ready for Distribution in Puerto Rico
INDIANAPOLIS, Oct. 5, 2017 /PRNewswire/ -- Today, a new shipment of commercial medicines, including more than 36,000 vials and pens of insulin, arrived in Puerto Rico. The delivery by Eli Lilly and Company (NYSE: LLY) includes 3,000 vials for humanitarian distribution and enough commercial insulin to help re-stock operational pharmacies. Lilly's hu...

September 29, 2017

Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing
INDIANAPOLIS, Sept. 29, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced a number of leadership changes, promoting several experienced Lilly leaders to executive roles, effective in 2018. Josh Smiley has been promoted to senior vice president and chief financial officer and will become a member of Lilly's executive...

September 7, 2017

Lilly Takes Steps to Streamline Business, Invest in New Medicines and Drive Growth
INDIANAPOLIS, Sept. 7, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced actions to streamline operations to more efficiently focus resources on developing new medicines and to improve its cost structure. Global workforce reductions, including those from a U.S. voluntary early retirement program, are expected to impact approxim...

Showing 1-8 of 8 Page: 1